201 related articles for article (PubMed ID: 34949928)
1. In Vitro Activity of Vancomycin, Teicoplanin, Linezolid and Daptomycin Against Methicillin-Resistant
Xu Y; Wang B; Zhao H; Wang X; Rao L; Ai W; Yu J; Guo Y; Wu X; Yu F; Chen S
Infect Drug Resist; 2021; 14():5449-5456. PubMed ID: 34949928
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin, teicoplanin, daptomycin, and linezolid MIC creep in methicillin-resistant Staphylococcus aureus is associated with clonality.
Hsieh YC; Lin YC; Huang YC
Medicine (Baltimore); 2016 Oct; 95(41):e5060. PubMed ID: 27741120
[TBL] [Abstract][Full Text] [Related]
3. Vancomycin, linezolid and daptomycin susceptibility pattern among clinical isolates of methicillin-resistant
Husain A; Rawat V; Umesh ; Kumar M; Verma PK
J Lab Physicians; 2018; 10(2):145-148. PubMed ID: 29692578
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of daptomycin & linezolid against methicillin resistant Staphylococcus aureus & vancomycin resistant enterococci isolated from hospitalized cases in Central India.
Chitnis S; Katara G; Hemvani N; Pareek S; Chitnis DS
Indian J Med Res; 2013 Jan; 137(1):191-6. PubMed ID: 23481072
[TBL] [Abstract][Full Text] [Related]
5. Worrisome trends in rising minimum inhibitory concentration values of antibiotics against methicillin resistant Staphylococcus aureus - Insights from a tertiary care center, South India.
Niveditha N; Sujatha S
Braz J Infect Dis; 2015; 19(6):585-9. PubMed ID: 26361841
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial activity of ceftaroline tested against staphylococci with reduced susceptibility to linezolid, daptomycin, or vancomycin from U.S. hospitals, 2008 to 2011.
Sader HS; Flamm RK; Jones RN
Antimicrob Agents Chemother; 2013 Jul; 57(7):3178-81. PubMed ID: 23629712
[TBL] [Abstract][Full Text] [Related]
7. Telavancin demonstrates activity against methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to vancomycin, daptomycin, and linezolid in broth microdilution MIC and one-compartment pharmacokinetic/pharmacodynamic models.
Smith JR; Barber KE; Hallesy J; Raut A; Rybak MJ
Antimicrob Agents Chemother; 2015 Sep; 59(9):5529-34. PubMed ID: 26124162
[TBL] [Abstract][Full Text] [Related]
8. [Investigation of antibiotic resistance patterns and reduced vancomycin susceptibilities of methicillin-resistant Staphylococcus aureus isolates: a multi-center study].
Çıkman A; Aydın M; Gülhan B; Parlak M; Gültepe B; Kalaycı Y; Bayındır Bilmen F; Solmaz S; Özekinci T
Mikrobiyol Bul; 2015 Apr; 49(2):240-8. PubMed ID: 26167824
[TBL] [Abstract][Full Text] [Related]
9. Glycopeptide minimum inhibitory concentration creep among meticillin-resistant Staphylococcus aureus from 2006-2011 in China.
Zhuo C; Xu YC; Xiao SN; Zhang GY; Zhong NS
Int J Antimicrob Agents; 2013 Jun; 41(6):578-81. PubMed ID: 23562222
[TBL] [Abstract][Full Text] [Related]
10. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.
Steinkraus G; White R; Friedrich L
J Antimicrob Chemother; 2007 Oct; 60(4):788-94. PubMed ID: 17623693
[TBL] [Abstract][Full Text] [Related]
11. Trends in the susceptibility of methicillin-resistant Staphylococcus aureus to nine antimicrobial agents, including ceftobiprole, nemonoxacin, and tyrothricin: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2006-2010.
Chen YH; Liu CY; Ko WC; Liao CH; Lu PL; Huang CH; Lu CT; Chuang YC; Tsao SM; Chen YS; Liu YC; Chen WY; Jang TN; Lin HC; Chen CM; Shi ZY; Pan SC; Yang JL; Kung HC; Liu CE; Cheng YJ; Liu JW; Sun W; Wang LS; Yu KW; Chiang PC; Lee MH; Lee CM; Hsu GJ; Hsueh PR
Eur J Clin Microbiol Infect Dis; 2014 Feb; 33(2):233-9. PubMed ID: 23955154
[TBL] [Abstract][Full Text] [Related]
12. Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to daptomycin, linezolid or vancomycin, and strains with defined SCCmec types.
Farrell DJ; Flamm RK; Sader HS; Jones RN
Int J Antimicrob Agents; 2014 Apr; 43(4):323-7. PubMed ID: 24411474
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of linezolid, tigecycline, and daptomycin on methicillin-resistant Staphylococcus aureus blood isolates from adult patients, 2006-2008: stratified analysis by vancomycin MIC.
Kao TM; Wang JT; Weng CM; Chen YC; Chang SC
J Microbiol Immunol Infect; 2011 Oct; 44(5):346-51. PubMed ID: 21524980
[TBL] [Abstract][Full Text] [Related]
14. Glycopeptide and daptomycin susceptibility trends among clinical isolates of methicillin-resistant Staphylococcus aureus in a tertiary care center in North India.
Singh A; Prasad KN; Rai RP; Singh SK; Rahman M; Tripathi A; Srivastava JK
J Infect Public Health; 2015; 8(4):341-5. PubMed ID: 25797814
[TBL] [Abstract][Full Text] [Related]
15. Comparative activity of oritavancin against meticillin-resistant Staphylococcus aureus (MRSA) bloodstream isolates from Geneva University Hospital.
Vaudaux P; Huggler E; Arhin FF; Moeck G; Renzoni A; Lew DP
Int J Antimicrob Agents; 2009 Dec; 34(6):540-3. PubMed ID: 19744838
[TBL] [Abstract][Full Text] [Related]
16. Staphylococcus aureus at an Indian tertiary hospital: Antimicrobial susceptibility and minimum inhibitory concentration (MIC) creep of antimicrobial agents.
Khurana S; Mathur P; Malhotra R
J Glob Antimicrob Resist; 2019 Jun; 17():98-102. PubMed ID: 30389637
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of daptomycin and comparator agents against Staphylococcus aureus isolates from intravenous drug users with right endocarditis.
Sanchez-Porto A; Casanova-Roman M; Casas-Ciria J; Santaella MJ; Sanchez-Morenilla I; Eiros-Bouza JM
Infez Med; 2010 Jun; 18(2):108-12. PubMed ID: 20610933
[TBL] [Abstract][Full Text] [Related]
18. Dynamic Changes of
Jian Y; Lv H; Liu J; Huang Q; Liu Y; Liu Q; Li M
Front Microbiol; 2020; 11():908. PubMed ID: 32528428
[TBL] [Abstract][Full Text] [Related]
19. Vancomycin and daptomycin minimum inhibitory concentration distribution and occurrence of heteroresistance among methicillin-resistant Staphylococcus aureus blood isolates in Turkey.
Sancak B; Yagci S; Gür D; Gülay Z; Ogunc D; Söyletir G; Yalcin AN; Dündar DO; Topçu AW; Aksit F; Usluer G; Ozakin C; Akalin H; Hayran M; Korten V
BMC Infect Dis; 2013 Dec; 13():583. PubMed ID: 24325260
[TBL] [Abstract][Full Text] [Related]
20. Activity of dalbavancin tested against Gram-positive clinical isolates causing skin and skin-structure infections in paediatric patients from US hospitals (2014-2015).
Pfaller MA; Mendes RE; Sader HS; Castanheira M; Flamm RK
J Glob Antimicrob Resist; 2017 Dec; 11():4-7. PubMed ID: 28735053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
